Cargando…
Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients
BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patien...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839844/ https://www.ncbi.nlm.nih.gov/pubmed/24294005 http://dx.doi.org/10.2147/IJNRD.S34299 |
_version_ | 1782478443361861632 |
---|---|
author | Haddiya, Intissar Hamzaoui, Hakim Tachfouti, Nabil Hamany, Zitouna Al Radoui, Aicha Zbiti, Najoua Amar, Yamama Rhou, Hakima Benamar, Loubna Ouzeddoun, Naima Bayahia, Rabea |
author_facet | Haddiya, Intissar Hamzaoui, Hakim Tachfouti, Nabil Hamany, Zitouna Al Radoui, Aicha Zbiti, Najoua Amar, Yamama Rhou, Hakima Benamar, Loubna Ouzeddoun, Naima Bayahia, Rabea |
author_sort | Haddiya, Intissar |
collection | PubMed |
description | BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patients. PATIENTS AND METHODS: We performed a single-center retrospective study. A total of 114 patients with LN were included. All patients met American Rheumatism Association criteria. LN was classified according to the International Society of Nephrology/Renal Pathology Society classification. We adopted previously defined outcome criteria for LN. RESULTS: There were 101 females and 13 males, with a mean age of 29.9 years. At first presentation, we noted hypertension in 33%, hematuria in 76%, nephrotic syndrome in 53%, and renal failure in 60% of cases. Renal biopsy revealed predominant proliferative classes in more than 80% of patients. Patients received different regimens mainly based on intravenous cyclophosphamide. After a mean follow-up of 22 months, remission occurred in 45.5%, relapses in 82%, end-stage renal failure in 21%, and death in 16% of cases. Infection and neurological and cardiovascular diseases were the most frequent causes of death. CONCLUSION: LN seems to be severe in our study, with a predominance of proliferative forms, severe renal manifestations, and poor renal and overall survival. |
format | Online Article Text |
id | pubmed-3839844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-38398442013-11-29 Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients Haddiya, Intissar Hamzaoui, Hakim Tachfouti, Nabil Hamany, Zitouna Al Radoui, Aicha Zbiti, Najoua Amar, Yamama Rhou, Hakima Benamar, Loubna Ouzeddoun, Naima Bayahia, Rabea Int J Nephrol Renovasc Dis Case Series BACKGROUND: There is wide variation in clinical presentation and outcome of lupus nephritis (LN) among different ethnic groups. Few data for LN exist on North Africans, especially those from Morocco. The aim of our study was to review retrospectively the features and outcome of LN in Moroccan patients. PATIENTS AND METHODS: We performed a single-center retrospective study. A total of 114 patients with LN were included. All patients met American Rheumatism Association criteria. LN was classified according to the International Society of Nephrology/Renal Pathology Society classification. We adopted previously defined outcome criteria for LN. RESULTS: There were 101 females and 13 males, with a mean age of 29.9 years. At first presentation, we noted hypertension in 33%, hematuria in 76%, nephrotic syndrome in 53%, and renal failure in 60% of cases. Renal biopsy revealed predominant proliferative classes in more than 80% of patients. Patients received different regimens mainly based on intravenous cyclophosphamide. After a mean follow-up of 22 months, remission occurred in 45.5%, relapses in 82%, end-stage renal failure in 21%, and death in 16% of cases. Infection and neurological and cardiovascular diseases were the most frequent causes of death. CONCLUSION: LN seems to be severe in our study, with a predominance of proliferative forms, severe renal manifestations, and poor renal and overall survival. Dove Medical Press 2013-11-22 /pmc/articles/PMC3839844/ /pubmed/24294005 http://dx.doi.org/10.2147/IJNRD.S34299 Text en © 2013 Haddiya et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Case Series Haddiya, Intissar Hamzaoui, Hakim Tachfouti, Nabil Hamany, Zitouna Al Radoui, Aicha Zbiti, Najoua Amar, Yamama Rhou, Hakima Benamar, Loubna Ouzeddoun, Naima Bayahia, Rabea Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title | Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title_full | Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title_fullStr | Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title_full_unstemmed | Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title_short | Features and outcomes of lupus nephritis in Morocco: analysis of 114 patients |
title_sort | features and outcomes of lupus nephritis in morocco: analysis of 114 patients |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839844/ https://www.ncbi.nlm.nih.gov/pubmed/24294005 http://dx.doi.org/10.2147/IJNRD.S34299 |
work_keys_str_mv | AT haddiyaintissar featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT hamzaouihakim featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT tachfoutinabil featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT hamanyzitounaal featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT radouiaicha featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT zbitinajoua featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT amaryamama featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT rhouhakima featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT benamarloubna featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT ouzeddounnaima featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients AT bayahiarabea featuresandoutcomesoflupusnephritisinmoroccoanalysisof114patients |